GPQ-18023-92454
4 vaccinations
4 coded responses
49 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 980 / WA
- Registered
- 2021-11-05
- Relationship
- Child or adolescent in my care
- Guardian
- ENS-21794-09597
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-05
Registered in v-safe
-
2021-11-05
Dose 1 — Pfizer-BioNTech
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-14
- 2021-11-19
- 2021-11-26
-
2021-11-29
Dose 2 — Pfizer-BioNTech
-
2021-11-29
Health check-in — day 0, dose 2, dependentFeeling: Good · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-11-30
- 2021-12-01
- 2021-12-02
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-01-10
- 2022-02-28
-
2022-05-30
Survey response — 6 months, dose 2, dependentMedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-08-04
Dose 3 — Pfizer-BioNTech
-
2022-08-05
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-08-06
- 2022-08-07
- 2022-08-08
- 2022-08-09
- 2022-08-10
- 2022-08-11
- 2022-08-18
- 2022-08-25
- 2022-09-01
- 2022-09-08
- 2022-09-17
- 2022-11-03
-
2022-12-27
Dose 4 — Moderna
-
2022-12-28
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
- 2022-12-30
- 2022-12-31
- 2023-01-01
- 2023-01-02
- 2023-01-03
- 2023-01-10
-
2023-01-17
Survey response — day 21, dose 4, dependentMedDRA: SARS-CoV-2 test negative, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-01-24
Survey response — day 28, dose 4, dependentMedDRA: Pyrexia, Respiratory tract congestion, Viral infection — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-02-02
- 2023-02-07
-
2023-03-28
Survey response — 3 months, dose 4, dependentMedDRA: Conjunctivitis, Ear infection, Metapneumovirus infection, Moraxella infection, Respiratory disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-28
Report sent to call center — 3 months, dose 4, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-29
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-06-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-05 | Pfizer-BioNTech | No |
| 2 | 2021-11-29 | Pfizer-BioNTech | No |
| 3 | 2022-08-04 | Pfizer-BioNTech | No |
| 4 | 2022-12-27 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 2, dependent
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Metapneumovirus infection | · | · | ✓ |
| SD | Moraxella infection | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release